CoChat

Update on Uses and Properties of Citrus Flavonoids: New Findings in Anticancer, Cardiovascular, and Anti-inflammatory Activity

Benavente-García, O., Castillo, J. · 2008 · Journal of Agricultural and Food Chemistry

The DOI matches its Crossref record; 197 of the 197 references it cites were found in a registry or an index.

Abstract

Significantly, much of the activity of Citrus flavonoids appears to impact blood and microvascular endothelial cells, and it is not surprising that the two main areas of research on the biological actions of Citrus flavonoids have been inflammation and cancer. Epidemiological and animal studies point to a possible protective effect of flavonoids against cardiovascular diseases and some types of cancer. Although flavonoids have been studied for about 50 years, the cellular mechanisms involved in their biological action are still not completely known. Many of the pharmacological properties of Citrus flavonoids can be linked to the abilities of these compounds to inhibit enzymes involved in cell activation. Attempts to control cancer involve a variety of means, including the use of suppressing, blocking, and transforming agents. Suppressing agents prevent the formation of new cancers from procarcinogens, and blocking agents prevent carcinogenic compounds from reaching critical initiation sites, while transformation agents act to facilitate the metabolism of carcinogenic components into less toxic materials or prevent their biological actions. Flavonoids can act as all three types of agent. Many epidemiological studies have shown that regular flavonoid intake is associated with a reduced risk of cardiovascular diseases. In coronary heart disease, the protective effects of flavonoids include mainly antithrombotic, anti-ischemic, anti-oxidant, and vasorelaxant. It is suggested that flavonoids decrease the risk of coronary heart disease by three major actions: improving coronary vasodilatation, decreasing the ability of platelets in the blood to clot, and preventing low-density lipoproteins (LDLs) from oxidizing. The anti-inflammatory properties of the Citrus flavonoids have also been studied. Several key studies have shown that the anti-inflammatory properties of Citrus flavonoids are due to its inhibition of the synthesis and biological activities of different pro-inflammatory mediators, mainly the arachidonic acid derivatives, prostaglandins E 2, F 2, and thromboxane A 2. The anti-oxidant and anti-inflammatory properties of Citrus flavonoids can play a key role in their activity against several degenerative diseases and particularly brain diseases. The most abundant Citrus flavonoids are flavanones, such as hesperidin, naringin, or neohesperidin. However, generally, the flavones, such as diosmin, apigenin, or luteolin, exhibit higher biological activity, even though they occur in much lower concentrations. Diosmin and rutin have a demonstrated activity as a venotonic agent and are present in several pharmaceutical products. Apigenin and their glucosides have been shown a good anti-inflammatory activity without the side effects of other anti-inflammatory products. In this paper, we discuss the relation between each structural factor of Citrus flavonoids and the anticancer, anti-inflammatory, and cardiovascular protection activity of Citrus flavonoids and their role in degenerative diseases.

Overview

Integrity signals

Registry

Crossref · 10.1021/jf8006568

Cites

197 of 197 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 197 references

Research works printed but not linked: 26

  1. Bär A., 1990, Food Sci. Technol., 23, 371
  2. Yañez J., 2002, Oncologia, 25, 210
  3. Martínez C., 2001, Rev. Esp. Patol., 34, 317
  4. Benavente-García O., 2005, Agro Food Ind. Hi-Tech, 4, 30
  5. Fotsis T., 1997, Cancer Res., 57, 2916
  6. Kawaii S., 1999, Anticancer Res., 19, 1261
  7. Kandaswami C., 2005, In Vivo, 19, 895
  8. Ohno T., 2001, Anticancer Res., 21, 3875
  9. Caltagirone S., 2000, J. Cancer, 87, 595
  10. Czyz J., 2004, Cancer Cell Biol., 114, 12
  11. Tanaka T., 2000, Cancer Res., 60, 3713
  12. Yoshikawa N., 2001, In Vivo, 15, 485
  13. Zhu Y., 2001, Int. J. Oncol., 18, 1299
  14. Tanaka T., 1997, Cancer Res., 57, 246
  15. Cova D., 1992, Int. J. Clin. Pharmacol. Ther. Toxicol., 30, 29
  16. Guerrero J. A., 2005, Thromb. Haemostasis, 2, 1
  17. Woodhouse E. C., 1997, Cancer, 80, 1529, 10.1002/(SICI)1097-0142(19971015)80:8+<1529::AID-CNCR2>3.0.CO;2-F · DOI · Paper page
  18. Szatrowsky T. P., 1991, Cancer Res., 51, 794
  19. Masferrer J. L., 2000, Cancer Res., 60, 1306
  20. Fotsis T., 1997, Cancer Res., 57, 2916
  21. Guzik T. J., 2000, Circ. Res., 86, E85
  22. Shono T., 1996, Mol. Cell. Biol., 16, 4231, 10.1128/MCB.16.8.4231 · DOI · Paper page
  23. Olszanecki R., 2002, J. Physiol. Pharmacol., 53, 571
  24. Monforte M. T., 1995, Pharmacology, 50, 595
  25. Middleton E., 2000, Pharmacol. Rev., 52, 673, 10.1016/S0031-6997(24)01472-8 · DOI · Paper page
  26. Schubert P., 1998, J. Neural Transm., 54, 167

Cited by

Items 701–800 of 1,000

Metadata

Authors
Benavente-García, O., & Castillo, J.
Affiliations
Universidad de Murcia (ES)
Corresponding author
Benavente-García, O.
Venue
Journal of Agricultural and Food Chemistry
Published
2008-07-02
Volume
56
Issue
15
Pages
6185-6205
ISSN
  • 0021-8561 (ISSN-L)
  • 1520-5118
OpenAlex
W1991774590
Cited by
1,158
References
196
Citations by year
2026: 33 · 2025: 42 · 2024: 63 · 2023: 60 · 2022: 85 · 2021: 74 · 2020: 80 · 2019: 83 · 2018: 80 · 2017: 81 · 2016: 60 · 2015: 82 · 2014: 75 · 2013: 59 · 2012: 73
FWCI
3.58
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Agricultural and Food Chemistry (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Bioactive Compounds in Plants
  • Health Sciences › Medicine › Biochemistry (medical) › Phytochemicals and Antioxidant Activities
  • Health Sciences › Medicine › Pharmacology (medical) › Flavonoids in Medical Research
Keywords
citrus flavonoids, flavonoids, anticancer activity, cardiovascular disease, anti-inflammatory activity, coronary artery disease, endothelial cells, flavanones, flavones, hesperidin, naringin, diosmin, rutin, apigenin, luteolin, LDL oxidation, platelet aggregation, prostaglandins, thromboxane
MeSH terms
Animals, Anti-Inflammatory Agents, Cardiovascular Diseases, Cell Division, Citrus, Flavonoids, Humans, Neoplasm Invasiveness, Neoplasms, Neovascularization, Pathologic, Anticarcinogenic Agents, Glycation End Products, Advanced

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.